United Therapeutics

United Therapeutics, a leader in researching and developing treatments for pulmonary arterial hypertension (PAH), wanted to raise awareness of the rare disease and provide information about newly developed treatments. There was little public-facing information on the disease at the time, so identifying primary sources and interviewing key opinion leaders was essential in developing content.  The result was LivingPAH.com, a first-of-its-kind website about the orphan disease, which became a go-to resource for medical centers that treated the condition, and Remodulin.com, a website dedicated to a new treatment option.

LivingPAH - website screen shot
Remodulin - website screen shot